Literature DB >> 16614005

Notch signaling is inactive but inducible in human embryonic stem cells.

Scott A Noggle1, Deborah Weiler, Brian G Condie.   

Abstract

The NOTCH signaling pathway performs a wide range of critical functions in a number of different cell types during development and differentiation. The role of NOTCH signals in human embryonic stem cells (hESCs) has not been tested. We measured the activity of canonical NOTCH signaling in undifferentiated embryonic stem (ES) cells and tested the requirement for NOTCH activity in hESC self-renewal or differentiation by growing hESCs in the presence of gamma-secretase inhibitors. Our results suggest that NOTCH signaling is not required for the propagation of undifferentiated human ES cells but instead is required for the maintenance of the differentiating cell types that accumulate in human ES cell cultures. Our studies suggest that NOTCH signaling is not required in human embryonic differentiation until the formation of extraembryonic, germ layer, or tissue-specific stem cells and progenitors.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16614005     DOI: 10.1634/stemcells.2005-0314

Source DB:  PubMed          Journal:  Stem Cells        ISSN: 1066-5099            Impact factor:   6.277


  14 in total

1.  Notch and hedgehog signaling cooperate to maintain self-renewal of human embryonic stem cells exposed to low oxygen concentration.

Authors:  Simon C Weli; Trine Fink; Cihan Cetinkaya; Mayuri S Prasad; Cristian P Pennisi; Vladimir Zachar
Journal:  Int J Stem Cells       Date:  2010-05       Impact factor: 2.500

2.  Notch signaling activation in human embryonic stem cells is required for embryonic, but not trophoblastic, lineage commitment.

Authors:  Xiaobing Yu; Jizhong Zou; Zhaohui Ye; Holly Hammond; Guibin Chen; Akinori Tokunaga; Prashant Mali; Yue-Ming Li; Curt Civin; Nicholas Gaiano; Linzhao Cheng
Journal:  Cell Stem Cell       Date:  2008-05-08       Impact factor: 24.633

Review 3.  Common stemness regulators of embryonic and cancer stem cells.

Authors:  Christiana Hadjimichael; Konstantina Chanoumidou; Natalia Papadopoulou; Panagiota Arampatzi; Joseph Papamatheakis; Androniki Kretsovali
Journal:  World J Stem Cells       Date:  2015-10-26       Impact factor: 5.326

4.  The Histone Variant MacroH2A Blocks Cellular Reprogramming by Inhibiting Mesenchymal-to-Epithelial Transition.

Authors:  Maria Pliatska; Maria Kapasa; Antonis Kokkalis; Alexander Polyzos; Dimitris Thanos
Journal:  Mol Cell Biol       Date:  2018-04-30       Impact factor: 4.272

5.  Transcriptional characterization of the Notch signaling pathway in rodent multipotent adult progenitor cells.

Authors:  Melinda Hajdu; Aernout Luttun; Beatriz Pelacho; Terry C Burns; Lucas Chase; María Gutiérrez-Pérez; Yuehua Jiang; Todd Lenvik; Virág Vas; Ferenc Uher; Anna Sebestyén; Catherine Verfaillie
Journal:  Pathol Oncol Res       Date:  2007-12-25       Impact factor: 3.201

6.  Hes1 regulates embryonic stem cell differentiation by suppressing Notch signaling.

Authors:  Taeko Kobayashi; Ryoichiro Kageyama
Journal:  Genes Cells       Date:  2010-06-10       Impact factor: 1.891

Review 7.  Pluripotent stem cells and their niches.

Authors:  M William Lensch; Laurence Daheron; Thorsten M Schlaeger
Journal:  Stem Cell Rev       Date:  2006       Impact factor: 5.739

Review 8.  Signaling pathways in cancer and embryonic stem cells.

Authors:  Oliver Dreesen; Ali H Brivanlou
Journal:  Stem Cell Rev       Date:  2007-01       Impact factor: 6.692

Review 9.  Pluripotent Stem Cells: Cancer Study, Therapy, and Vaccination.

Authors:  Mojgan Barati; Maryam Akhondi; Narges Sabahi Mousavi; Newsha Haghparast; Asma Ghodsi; Hossein Baharvand; Marzieh Ebrahimi; Seyedeh-Nafiseh Hassani
Journal:  Stem Cell Rev Rep       Date:  2021-06-11       Impact factor: 5.739

10.  Notch signaling is required for maintaining stem-cell features of neuroprogenitor cells derived from human embryonic stem cells.

Authors:  Sun-Mi Woo; Janghwan Kim; Hyo-Won Han; Jung-Il Chae; Mi-Young Son; Sunwha Cho; Hyung-Min Chung; Yong-Mahn Han; Yong-Kook Kang
Journal:  BMC Neurosci       Date:  2009-08-17       Impact factor: 3.288

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.